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REGULAR ARTICLE
Sptlc1 is essential for myeloid differentiation and
hematopoietic homeostasis
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1Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD; 2Genomic Medicine Institute and 3Lerner Research
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Key Points
• Sptlc1 is essential for
myeloid differentiation
during hematopoiesis;
ER stress prevents my-
eloid development in
Sptlc1 mutant mice.
• Accumulation of fatty
acid promotes ER
stress in Sptlc1 mutant
myeloid progenitors.
Serine palmitoyltransferase (SPT) long-chain base subunit 1 (SPTLC1) is 1 of the 2 main
catalytic subunits of the SPT complex, which catalyzes the first and rate-limiting step of
sphingolipid biosynthesis. Here, we show that Sptlc1 deletion in adult bone marrow (BM)
cells results in defective myeloid differentiation. In chimeric mice from noncompetitive BM
transplant assays, there was an expansion of the Lin2 c-Kit1 Sca-11 compartment due to
increased multipotent progenitor production, but myeloid differentiation was severely
compromised. We also show that defective biogenesis of sphingolipids in the endoplasmic
reticulum (ER) leads to ER stress that affects myeloid differentiation. Furthermore, we
demonstrate that transient accumulation of fatty acid, a substrate for sphingolipid
biosynthesis, could be partially responsible for the ER stress. Independently, we find that ER
stress in general, such as that induced by the chemical thapsigargin or the fatty acid palmitic
acid, compromises myeloid differentiation in culture. These results identify perturbed
sphingolipid metabolism as a source of ER stress, which may produce diverse pathological
effects related to differential cell-type sensitivity.
Introduction
Sphingolipids are components of all eukaryotic cell membranes and are vital for the survival of organisms
from yeast to mammals.1-10 Serine palmitoyltransferase (SPT) catalyzes the condensation of palmitoyl-CoA
and serine to 3-ketosphinganine, a regulated rate-limiting step in the de novo biosynthetic pathway of
sphingolipids in the endoplasmic reticulum (ER). The mammalian SPT holoenzyme is primarily
a heterotrimeric complex composed of SPT long-chain base subunit 1 (SPTLC1; 53 kDa), SPTLC2
(63 kDa), and small subunit of SPTa (ssSPTa) or ssSPTb (10 kDa).11-17 SPTLC1 and SPTLC2 are
part of the catalytic subunit whereas the small subunits confer substrate specificity. Previous studies
have identified SPTLC1 as a critical determinant of SPT enzymatic activity and sphingomyelin
synthesis and as a regulator of gastrulation.18 Deficiency of SPTLC2 in the liver resulted in impaired liver
function.19 A mutation in the small subunit of the SPT complex, ssSPTb, results in neurodegeneration.20
Sptlc1 andSptlc2 knockouts are embryonically lethal, necessitating the use of conditional knockout (CKO)
mice to study their function in adult organisms.18
Adult hematopoietic progenitor cells are the major source of mature blood cells produced daily, and in
humans those production numbers reach more than several hundred billion per day.21 Hematopoiesis is
a highly regulated process that occurs mainly in the bone marrow (BM) microenvironment (niche) where
blood cells are derived from hematopoietic stem cells (HSCs). During myeloid differentiation, HSCs
Submitted 22 July 2019; accepted 7 October 2019. DOI 10.1182/
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*D.A. and S.M.S. contributed equally to this work.
Send data sharing requests via e-mail to Jairaj K. Acharya at (acharyaj@mail.nih.gov).
The full-text version of this article contains a data supplement.
26 NOVEMBER 2019 x VOLUME 3, NUMBER 22 3635
D
ow
nloaded from
 https://ashpublications.org/bloodadvances/article-pdf/3/22/3635/1542516/advancesadv2019000729.pdf by U
N
IV O
F M
ASSAC
H
U
SETTS user on 04 D
ecem
ber 2019
commit to the formation of multipotent progenitors (MPPs), which
further differentiate to form common myeloid progenitors (CMPs)
and, subsequently, bipotent granulocyte-macrophage progenitors
(GMPs) or megakaryocyte/erythrocyte progenitors (MEPs) that
undergo terminal differentiation to granulocytes/macrophages or
megakaryocytes/erythrocytes, respectively. Depending on the needs
of the organism, these cells form unipotent progenitors and,
eventually, terminally differentiated granulocytes or macrophages.22
There is keen interest in understanding the contextual significance
of metabolic processes during differentiation in several systems,
including hematopoiesis.23 The focus has been primarily on energy
metabolism, specifically during stem cell maintenance and commit-
ment to differentiation.23-25 Not all metabolic requirements neces-
sary for specification along committed lineages are understood. We
report here that SPTLC1 is essential for myeloid differentiation in
adult hematopoietic tissue. Mx1-Cre–induced deletion of Sptlc1
results in reduced de novo biosynthesis of major sphingolipids and
severely impaired myelopoiesis. The Sptlc12/2 lineages are poorly
represented in competitive BM repopulation conditions. When the
proportion of Sptlc12/2 HSCs is increased by providing more
donor cells, the profile of the mutant BM cells (BMCs) appears
similar to that observed in noncompetitive chimeric mice. In chimeric
noncompetitive BM transplantation (BMT) studies, HSCs and MPPs
are expanded and differentiation of the committed progenitors into
myeloid progeny is affected in the mutant. The lack of sphingolipid
synthesis in mutant BMCs leads to ER stress and compromises
differentiation along the myeloid lineage. The ER stress occurs during
the differentiation process in the LK cells that leads to the activation
of apoptosis and death of these cells. We demonstrate that
accumulation of fatty acid in the mutant cells can partly explain the
observed ER stress. Induction of ER stress in wild-type BMCs using
chemical inhibitors or fatty acid also suppresses differentiation along
the myeloid pathway while sparing erythroid differentiation.
Methods
Our animal studies have been approved by the National Cancer
Institute Animal Care andUser Committee (protocol number 17-073).
Targeting of Sptlc1 gene and mice strain
The details of the targeting strategy and genetic cross for
Mx1-Cre–mediated deletion of Sptlc1 (Sptlc12/2) are elaborated
in supplemental Methods.
Tissue culture and differentiation
Myeloid colony formation and differentiation of myeloid cultures
were performed as described.26 The erythroid differentiation
protocol was based on a previously described method.27
Immunophenotyping and BMT studies
Immunophenotyping was based on published protocols.26,28 BMT
studies were as described.29
Sphingolipid analysis
Mass spectrometric estimation of sphingolipids was performed as
in our previous studies.30
Single-cell messenger RNA sequencing
Single-cell samples were prepared using the 103 chromium
workflow and sequenced on 2 NextSeqs as 4 samples per run.
The 103 data set was analyzed by Seurat, an R package tool
designed for analysis of single-cell RNA-sequencing (RNA-seq)
data31 (satijalab.org/seurat/immune_alignment.html).
Statistical analysis
Our data were analyzed by 2-tailed unpaired Student t tests with
Welch correction. Results were presented as the means and
standard deviations of groups, with P , .05 considered to be
statistically significant.
Results
SPTLC1 deficiency in adult hematopoietic cells affects
BM and spleen
As Sptlc1 knockouts are embryonically lethal, we generated
a CKO allele using the standard Cre-lox system and Bac recom-
bineering (supplemental Figure 1A).18,32 We used Mx1-Cre
transgenic mice to induce deletion of the floxed allele to study
the adult hematopoietic system.33 Genotypes were confirmed by
polymerase chain reaction (PCR) (supplemental Figure 1B). The
Sptlc11/1Mx1-Cre and Sptlc1flox/nullMx1-Cre mice were admin-
istered intraperitoneal injections of 500 mg of poly(I:C) to induce
Cre-recombinase expression and delete Sptlc1 (Sptlc12/2) in
BMCs. Although no mortality was observed in the controls, the
Sptlc12/2 mice died 4 days after the injection due to disruption of
intestinal integrity (supplemental Figure 1C), fluid accumulation,
and complications thereof caused by deletion of Sptlc1 in non-
hematopoietic tissues (data not shown). Accordingly, all hematopoi-
etic analyses in direct conditional knockouts were conducted 3 days
after administration of poly(I:C). The gene is uniformly expressed in
most lineages of the hematopoietic system with elevated levels in
GMPs and MEPs (supplemental Figure 1D). The loss of SPTLC1
protein in BMCs was confirmed by western blotting (Figure 1A).
Levels of sphingomyelins, ceramides, and hexosylceramides were
significantly decreased in the Sptlc12/2 BMCs30 (Figure 1B;
supplemental Table 1). Freshly isolated preparations of Sptlc12/2
BMCs were unusually red in color and cytocentrifuge preparations
exhibited fewer myeloid cells including metamyelocytes as well as
segmented and band neutrophils, whereas the proportion of erythroid
cells was apparently higher (Figure 1C-D). The cellularity of the
Sptlc12/2 BM was decreased (Figure 1E). Peripheral blood cell
(PBC) analysis showed no significant differences in the blood cells
of the Sptlc12/2 mice on the third day postinjection (supplemental
Figure 1E). The size and cellularity of the spleen was reduced in
Sptlc12/2 (supplemental Figure 1F-G) and splenic architecture
was disrupted (supplemental Figure 1H). The loss of SPTLC1 had
minimal effect on the thymus (supplemental Figure 1I). There were
no significant differences in BM lineages inSptlc1flox/nullMx1-Crewithout
induction by poly(I:C) compared with the control Sptlc11/1Mx1-Cre
(supplemental Figure 1J-N). These results show that global loss of
Sptlc1 in the adult hematopoietic system results in reduced
sphingolipid levels in BMCs and leads to a rapid depletion of
mature myeloid cells in the BM, whereas RBCs and lymphoid cells
are less affected.
SPTLC1 deficiency in hematopoietic cells severely
compromises myelopoiesis
To determine how loss of Sptlc1 affects hematopoietic lineage
development 3 days after deletion in BMCs, we analyzed BMCs,
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thymocytes, and splenocytes for lineage markers expressed on
myeloid cells (Mac-1; Gr-1), erythroid cells (CD71; Ter119), B
lymphoid cells (immunoglobulin M [IgM]), and T lymphocytes
(CD4; CD8) by flow cytometry. Granulocytes (Mac-11; Gr-11)
were severely depleted in the Sptlc12/2 BM compared with
littermate controls (more than sevenfold) (Figure 1F-G). The spleen
also showed a significant reduction in granulocytes (Figure 1H;
supplemental Figure 2A). The proportion of mature erythroid cells
(CD712; Ter1191) was increased in the BM whereas the cellularity
was unchanged (Figure 1I-J). The CD41, CD81, and CD41CD81
thymocytes were not significantly affected (supplemental Figure 2B-D).
B cells marked by IgM were decreased in Sptlc12/2, albeit with
50
<0.0001
****
Sp
hin
go
m
ye
lin
(p
m
ol/
g 
of
 c
ar
bo
n)
40
30
20
10
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
3
<0.0001
****
Ce
ra
m
ide
(p
m
ol/
g 
of
 c
ar
bo
n)
2
1
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
2.5
<0.0001
****
He
xo
sy
lce
ra
m
ide
(p
m
ol/
g 
of
 c
ar
bo
n)
2.0
1.5
1.0
0.5
0.0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
B
kDa +/+ -/-
54
44
SPTLC1
Actin
A
+/+ +/+ -/- -/-
Sptlc1
C
0.0018
**
%
 C
D7
1- T
er
119
+  B
M 
ce
lls 100
20
40
60
80
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
I
10
<0.0001
****
Ma
c1
+ G
r1
+  B
M 
ce
lls
(X
10
6 )
8
6
4
2
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
G
ns
CD
71
- Te
r11
9+
 B
M 
ce
lls
(X
10
6 )
20
5
10
15
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
J
0.0112
*
Ma
c1
+ G
r1
+  s
ple
en
 c
ell
s
(X
10
6 )
2
1
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
HF
Sptlc1+/+ Sptlc1-/-
Ma
c1
Gr1
30
0.0121
*
Ce
llu
lar
ity
 p
er
 2
 b
on
es
(X
10
6 ) 20
10
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
E
Sptlc1-/-Sptlc1+/+
50 m
D
Figure 1. Deletion of Sptlc1 in mice using Mx1-Cre affects BM and spleen. (A) Western blot analysis for the loss of SPTLC1 protein in the Sptlc12/2 BMCs.
(B) Sphingomyelin, ceramide, and hexosylceramide were analyzed by mass spectrometry and normalized to carbon content. The sphingomyelin levels were 38.5 6 3 and
15 6 0.4 pmol per microgram of carbon, the total ceramides were 2.5 6 0.14 and 0.8 6 0.1 pmol per microgram of carbon, and the hexosylceramides were 2.1 6 0.09 and
1 6 0.02 pmol per microgram of carbon in the Sptlc11/1 and Sptlc12/2 BMCs, respectively. The results are from technical triplicates performed on BM cells from 3 mice of
each genotype. (C) Representative images of BM tissue isolated from Sptlc11/1 and Sptlc12/2 mice. (D) Wright-Giemsa staining of BMCs from the Sptlc11/1 and Sptlc12/2
mice. 1, RBC; 2, metamyelocyte; and 3, segmented band cell. Scale bar, 50 mm. (E) BM cellularity was determined from 2 femurs on day 3 in the Sptlc11/1 and Sptlc12/2
mice. (F) Myeloid differentiation in BM hematopoietic cells was analyzed by Mac-1 and Gr-1 staining 3 days after poly(I:C) injection (n 5 4). (G) The total numbers of Mac-
11Gr-11 cells were plotted for the Sptlc11/1 and Sptlc12/2 mice (n 5 4). (H) Myeloid differentiation in spleens obtained from Sptlc11/1 and Sptlc12/2 mice was analyzed by
Mac-1 and Gr-1 staining (n 5 4). (I) The percentage of CD712Ter1191 BMCs was plotted for the Sptlc11/1 and Sptlc12/2 mice (n 5 4). (J) The total numbers of
CD712Ter1191 BMCs were plotted for the Sptlc11/1 and Sptlc12/2 mice (n 5 4). All graphs are represented as mean 6 standard error of the mean (SEM). P , .05 is
significant, calculated from the unpaired Student t test. ns, not significant.
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marginal significance (supplemental Figure 2E). Thus, SPTLC1
deficiency impairs granulocyte development, whereas erythroid
and lymphoid development are relatively spared. To determine the
intrinsic requirement of SPTLC1 in hematopoiesis, we trans-
planted Sptlc11/1Mx1-Cre and Sptlc1Flox/nullMx1-Cre BMCs in
noncompetitive and competitive BM repopulation assays.29,34
In noncompetitive assays, chimeric mice were treated with poly(I:C)
(15 mg per gram of body weight, followed by a second dose 2 days
later) 6 weeks after transplantation of Sptlc11/1 and Sptlc1flox/null
BMCs. The majority of chimeric Sptlc12/2 mice did not survive
beyond 4 to 5 weeks and therefore we analyzed mice 3 weeks after
the last injection, when the mice appeared healthy. We have not
resolved the cause of death in noncompetitive chimeric mice.
Analysis of PBCs showed reduced neutrophils, lymphocytes, and
monocytes but red blood cells (RBCs) and platelets were not
compromised (Figure 2A-F). BM cellularity of Sptlc12/2 mice was
decreased by 38% compared with the control (Figure 2G). Total
donor Mac-11Gr-11 neutrophils were decreased by 83% (roughly
fivefold), suggesting that SPTLC1 is intrinsically required for the
development of granulocytes (Figure 2H-I). Macrophages and
monocytes were similarly compromised (Figure 2J-K). Because
CD45 is expressed in the early stages of erythroid development, we
examined BMCs for donor erythroid progenitor cells, and found that
these cells were increased in the BM of Sptlc12/2 mice, indicating
that erythroid development was not compromised at this time
(Figure 2L-N). The total number of Sptlc12/2 thymocytes was
decreased (supplemental Figure 2F). However, there was no difference
in the percentage of donor-derived CD41, CD81, and CD41CD81
T lymphocytes between Sptlc11/1 and Sptlc12/2 chimeric mice
(supplemental Figure 2G-L), indicating that the differentiation of T
lymphocytes was largely unaffected in the thymus of the transplanted
mice at this time. Finally, we observed no significant difference in
B-lymphoid cells in the BM of Sptlc11/1 and Sptlc12/2 chimeric mice
(supplemental Figure 2M). Thus, a defect in the development of the
myeloid cells is the predominant effect on lineage development in mice
3weeks after the loss of SPT function in the adult hematopoietic system.
To evaluate the intrinsic role of SPTLC1 in HSC development, we
evaluated loss of Sptlc1 in a competitive BMT assay, in which all
mice survived. Sptlc12/2 HSCs showed little or no contribution to
donor hematopoietic reconstitution (2% to 4%) 12 weeks after
Sptlc1 deletion compared with 40% to 60% for control BMCs in
this model, suggesting that SPTLC1 is required for HSC de-
velopment (supplemental Figure 2N). Sptlc12/2 donor myeloid,
B-cell, and erythroid cells were lost, and few cells were present
12 weeks after deleting Sptlc1 (supplemental Figure 2O-Q).
Similarly, HSC and progenitor cell (HSPC) analysis showed few
donor long-term HSCs (LT-HSCs) (CD342; Flt32), short-term
HSCs (ST-HSCs) (CD341;Flt32), and MPPs (CD341;Flt31)
present in mice 12 weeks after deletion of Spltc1 indicating that
SPTLC1 is required for HSC development (supplemental Figure 2R-
T). Because, in a competitive setting, the competing control BM
HSPCs engage in active hematopoiesis and rescue any deficits
caused by Sptlc1 deletion, the mutant HSPCs were relieved of the
requirement to maintain homeostasis. We asked whether increasing
the proportion of mutant HSPCs would allow us to evaluate their
differentiation potential in a competitive environment. Therefore, we
performed transplantation studies with a 1:8 population of wild-
type (Sptlc11/1 Mx1-Cre) to mutant (Sptlc1flox/null Mx1-Cre) cells.
Using this protocol, sufficient mutant BMCs populate the marrow after
poly(I:C) injection (Figure 2O). Specifically, we found that Sptlc12/2
knockout BMCs show hematopoietic phenotypes similar to those
observed in the noncompetitive chimeric mouse model. There is
a relative expansion of the LSK compartment, including the MPP cells
(Figure 2P-R). In the LK compartment, a trend toward decreasing
GMPs and the MEPs is relatively increased (Figure 2S-T). Finally, we
see decreased granulocytic development whereas erythroid and
lymphoid compartments are relatively expanded (Figure 2U-W). This
setting allowed determination of the cell-autonomous effects of Sptlc1
deletion and was found to encompass both HSCs and all lineages
downstream. The requirement for Sptlc1 in HSC development in
a competitive setting needs further study. To understand themechanism
underlying the failure to promote myelopoiesis in the absence of Sptlc1,
we turned to a noncompetitive chimeric mouse model because under
these conditions the Sptlc12/2 HSPC cells show robust reconstitution
to dissect myeloid, erythroid, and lymphoid lineages.
Increased ST-HSCs and MPP cells in
SPTLC1-deficient BM
To understand how loss of Sptlc1 leads to defects in myelogenesis,
we evaluated HSPC development in the chimeric mice 21 days
after loss of Sptlc1. HSCs were gated by forward scatter (FSC) and
side scatter (SSC) for live cells, CD45.2 donor cells, and then
lineage-negative cells (Lin2) (supplemental Figure 3A). Next, Lin2
cells were further analyzed for the expression of c-Kit and Sca-1,
identifying stem and MPP cells (LSK) and committed progenitor
cells LK (Lin2; c-Kit1; Sca-12) (Figure 3A). LSK cells include LT-
HSCs, ST-HSCs, and MPPs (supplemental Figure 3B). We found
that the total number of LSK cells in the BM was increased 7.9-fold
in Sptlc12/2 chimeric mice compared with the Sptlc11/1 (Figure 3B).
Although little difference was observed in the numbers of LT-HSCs
(Figure 3C), ST-HSCs (9.2-fold), and MPPs (8.8-fold) were signifi-
cantly increased in BM from Sptlc12/2 mice when compared with the
controls (Figure 3D-E). When gated using SLAM markers CD48 and
CD150, the ST-HSCs were slightly reduced, whereas LT-HSCs was
unaffected and MPPs were increased (Figure 3F-H). Analysis of the
MPP cells using antibodies that recognize Flt3, CD150, and CD48
indicated an increase in all 3 subpopulations of MPP (MPP2, MPP3,
and MPP4), demonstrating that MPPs were responsible for the
increase in the LSK numbers (Figure 3I-K; supplemental Figure 3C-F).
These 3 subpopulations of MPPs express Sptlc1 including slightly
higher levels in MPP2 cells (supplemental Figure 3G) although the
significance is not clear at this time.
We analyzed the LK compartment for progenitors including CMPs
(CD341; FcR2), GMPs (CD341; FcR1), and MEPs (CD342;
FcR2) (supplemental Figure 3H).35 Overall, LK cells were
significantly reduced (2.1-fold) in the BM of chimeric Sptlc12/2
mice (Figure 3L). The donor CMPs (3.5-fold) and GMPs (threefold)
were also reduced in Sptlc12/2 (Figure 3M-N). The MEP population
was not significantly affected in the Sptlc12/2 BM at this time
(Figure 3O), which confirms the observation that erythropoiesis is
less affected than granulopoiesis. Taken together, these results
suggest a defect in the production of CMPs/GMPs from MPPs
whereas the generation of MEPs is not compromised.
Single-cell RNA-seq reveals lack of committed
myeloid progenitors
We performed single-cell RNA-seq analysis on fluorescence-
activated cell sorter (FACS)-purified MPP and LK populations of
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Figure 2. Sptlc1 deletion impairs myeloid differentiation in chimeric mice and compromises HSC development in competitive repopulation studies. (A-N)
Studies done in chimeric noncompetitive repopulations studies. (A-F) Complete blood count (CBC) analysis of peripheral blood white blood cell (WBC), neutrophil, lymphocyte,
monocyte, RBC, and platelet (PLT) counts 21 days after poly(I:C) injection for noncompetitive BMT Sptlc11/1 and Sptlc12/2 mice (n 5 4). (G) Total BM cellularity was
determined for the Sptlc11/1 and Sptlc12/2 21 days after poly(I:C) injection in chimeric mice (n 5 11). (H) Myeloid differentiation in BMCs was analyzed by Mac-1 and Gr-1
staining. (I) The total numbers of Mac-11Gr-11 cells were plotted for the Sptlc11/1 and Sptlc12/2 (n 5 11). (J) The total numbers of Ly6C1Ly6G2 cells were plotted for the
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cells to understand the underlying transcriptional landscape of
differentiating cells.36,37 The Sptlc11/1 and Sptlc12/2 LK data sets
were integrated and analyzed as 1 data set, allowing identification of
cell types and markers conserved in both data sets and also
comparison of the data sets due to SPTLC1 deletion within the
clusters. The 2 data sets were integrated using canonical
correlation analysis (CCA) to identify the common source of
variation and then single integrated analysis on all the cells was
performed using T-distributed stochastic neighbor embedding
(t-SNE). This resulted in 16 clusters (C0-C15) and all clusters
except C13 (only Sptlc11/1 cells) and C14 (only Sptlc12/2 cells)
had cells from both data sets (Figure 4A-B). The clusters were
identified based on the expression of known lineage and stem cell
markers.38 Cluster C0 expresses erythroid progenitor markers Kif1,
Apoe, Gata1, Gata2, Car1/2, Meis1, and Itga2b (CD41), suggest-
ing that it belongs to the MEP population (supplemental Figure 4A).
Clusters C2, C6, and C15 express erythroid markers, and with the
exception of C15 they express late erythroid marker Rhd,
suggesting that they are more committed to forming erythroid
progenitors (supplemental Figure 4A). Clusters C1, C3, C4, C5,
C7, C9, and C13 express myeloid markers Elane, Ctsg, and Prtn3,
suggesting myeloid-primed clusters (supplemental Figure 4B).
Figure 2. (continued) Sptlc11/1 and Sptlc12/2 (n 5 5). (K) The total numbers of Mac-11 F4/801 cells were plotted for the Sptlc11/1 and Sptlc12/2 (n 5 5). (L) Erythroid
differentiation in transplanted BMCs was analyzed by CD71 and Ter119 staining. (M) The percentage of CD712Ter1191 cells was plotted for the Sptlc11/1 and Sptlc12/2
mice (n 5 11). (N) The total numbers of CD712Ter1191 cells were plotted for the transplanted Sptlc11/1 and Sptlc12/2 mice (n 5 11). (O-W) Studies done in competitive
repopulation studies ratio (1:8), analyzed 3 weeks after poly(I:C) injection. The percentages of donor CD45.2 cells (O), donor Lin2 c-Kit1 Sca-11 (LSK) cells (P), donor ST-
HSCs (Q), donor MPP cells (R), donor GMP cells (S), donor MEP cells (T), donor myeloid cells (U), donor erythroid cells (V), and donor lymphoid cells (W) of Sptlc11/1 and
Sptlc12/2 in competitive transplant studies were plotted. All graphs are represented as mean 6 SEM. P , .05 is significant, calculated from the unpaired Student t test.
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Figure 3. Sptlc1 deletion affects myeloid progenitors and increases ST-HSC and MPP populations in BMT cells. (A) The LSK and LK populations of HSPCs from
transplanted BM were analyzed by Sca-1 and c-Kit staining 21 days after poly(I:C) injection. (B) The total number of LSK cells was plotted for the Sptlc11/1 and Sptlc12/2
mice (n 5 11). (C-E) The total numbers of LT-HSCs, ST-HSCs, and MPPs were plotted for the Sptlc11/1 and Sptlc12/2 mice (n 5 11). (F-H) The total numbers of CD1501
CD482, CD1502CD482, and CD1502CD481 were plotted for the Sptlc11/1 and Sptlc12/2 mice (n 5 11). (I-K) The total numbers of MPP2, MPP3, and MPP4 were plotted
for the Sptlc11/1 and Sptlc12/2 mice (n 5 11). (L) The total number of LK cells was plotted for the Sptlc11/1 and Sptlc12/2 mice (n 5 11). (M-O) The total numbers of
CMPs, GMPs, and MEPs were plotted for the Sptlc11/1 and Sptlc12/2 mice (n 5 11). All graphs data are represented as mean 6 SEM. P , .05 is significant, calculated
from the unpaired Student t test.
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However, clusters C1 and C9 also express granulocyte-specific
marker Cebpe, suggesting a granulocytic bias in this cluster,
whereas C3, C5, and C7 express Irf8, suggesting a monocytic fate
(supplemental Figure 4B). C11 is a cell cluster expressing markers
of dendritic cells (Cd74 and Irf8) and C8 displays markers of the
megakaryocyte lineage (Pf4) (supplemental Figure 4B-C). Heat
maps showing relative expression of these cluster-specific markers
between the 2 genetic backgrounds clearly illustrate the down-
regulation of myeloid genes in the Sptlc12/2 LK cells in all clusters
(Figure 4C). Violin plots for the myeloid gene Mpo showed
a significant decrease in the Sptlc12/2 LK cells within individual
clusters (Figure 4D). The relative expression of erythroid markers
was not changed significantly between the Sptlc11/1 and
Sptlc12/2, however the number of cells expressing erythroid markers
were significantly higher in Sptlc12/2 LK clusters (Figure 4C,E). This
indicates that in the Sptlc12/2 BM LK population, cells were more
frequently primed for the erythroid lineage (;65% cells) than the
myeloid lineage (;16% cells). On the other hand, Sptlc11/1 LK cells
showed a myeloid bias with ;50% cells primed for myeloid lineage
and;20% cells primed for erythroid lineage. Both Sptlc11/1 (;24%)
and Sptlc12/2 (;14%) LK cells had clusters of cells with markers
indicating multilineage potential, albeit to a lesser degree in Sptlc12/2
(Figure 4F).
A similar analysis in Sptlc11/1 and Sptlc12/2 MPP cells resulted in
12 clusters (Figure 4G) with similar percentages of cells from both
data sets in all clusters except C6 and C11 (supplemental
Figure 4D). Cluster C6 showed dendritic cell fate as it expressed
Cd74 and Irf8 (supplemental Figure 4E). Interestingly, cluster C11
contained very few cells and was almost exclusively composed of
Sptlc12/2 MPPs (41 cells vs 2 Sptlc11/1 cells) (supplemental
Figure 4F). Clusters C0, C1, C2 C4, C5, C7, C10, C11, and C12
express not only myeloid marker Mpo but also erythroid markers
Apoe andMeis1, suggesting multilineage potential. In addition, cells
in cluster C5 express Irf8 and Elane, suggesting granulocyte-
macrophage bias. Only 1 cluster, C8, expresses both the erythroid
markers Apoe and Gata1 (supplemental Figure 4G); curiously,
Sptlc12/2 MPP displays a twofold increase in this cluster of cells
whereas the rest of the myeloid clusters were similarly populated by
both cell types (supplemental Figure 4H). Cluster C11 expressed
myeloid markers Mpo and Elane, suggesting that this was
a committed myeloid cluster. Intriguingly, this cluster of MPP cells
from Sptlc12/2 expresses the ER stress genes Pdia4, Hspa5,
Pdia6, Xbp1, and Hsp90b1 (Figure 4H; supplemental Figure 4I). In
conclusion, single-cell RNA-seq analysis of MPP and LK cells indicates
that the defects in myelopoiesis in Sptlc12/2 cells mostly begin in the
LK compartment.
The analysis of the LK compartment complemented the FACS data
in confirming the proportion of different lineages, however, we did
not obtain information regarding possible defects in the myeloid
progenitors. Total RNA-seq analysis was also performed at an
earlier time point, 7 days after poly(I:C) injection. Although RNA-seq
analysis generally confirmed the findings of the single-cell RNA-seq
experiment, we were unable to obtain potential mechanistic insight
into defects in myeloid differentiation in Sptlc12/2 BMCs. Hallmark
pathway analysis data are shown in supplemental Figure 4J. In
HSCs and MPPs, we see upregulation of MYC targets, mTORC1
signaling and oxidative phosphorylation pathway genes in the
mutant, whereas in the LK compartment these genes are
upregulated in the wild-type cells. Interestingly, heme metabolism
genes are upregulated in all 3 examined compartments of the
Sptlc12/2. As observed in single-cell RNA-seq analysis, gene-set
enrichment analysis (GSEA) profiles indicated that genes of myeloid
lineage were abundant in the wild-type LK compartment whereas the
mutant was enriched for erythroid markers (Figure 4I). Surprisingly, the
control MPPs in general had more robust expression of both myeloid
and erythroid lineage genes compared with the mutant cells
(Figure 4J). Although this highlights a differential expression pattern,
the mutant MPPs are still capable of robustly differentiating into MEPs
and mature erythrocytes. Although both single-cell RNA-seq and total
RNA-seq data confirm the loss of myeloid progenitors in the LK
compartment, we were unable to decipher a cause for failure of
myeloid differentiation in Sptlc12/2 BM.
Differentiation defects in Sptlc12/2 BM cells in culture
To determine the mechanism(s) for how loss of Sptlc1 prevents
myeloid cell development, we used in vitro BMC culture experi-
ments.26 Granulocyte/macrophage colony formation was reduced
by 72% for the LSK and 75% for the LK cells derived from the
Sptlc12/2 chimeric mice (7 days) (Figure 5A-B). In liquid medium
containing interleukin 3 (IL-3) and granulocyte macrophage colony-
stimulating factor (GM-CSF), Sptlc12/2 Lin2 cells showed a 92.7%
reduction in Mac-11Gr-11 cells compared with the control after
4 days of culture (Figure 5C-D). Similar results were obtained with
BMCs obtained from direct injection of poly(I:C) (supplemental
Figure 5A). Cytocentrifuge preparations of Sptlc12/2BMC cultures
confirmed the block in myeloid development (supplemental
Figure 5B-D). Cleaved caspase 3 was increased in these cells,
suggesting that Sptlc12/2 cells were undergoing apoptosis, which
could account for the decrease in cell viability observed in these
cultures (Figure 5E; supplemental Figure 5E). Annexin V and
propidium iodide (PI)–positive cells were increased in the LK but
not the LSK cells of the Sptlc12/2 in chimeric mice 21 days after
the Sptlc1 deletion, indicating that SPTLC1 is more critical for LK
survival in vivo (Figure 5F-G). BMCs were cultured in erythropoietin
(EPO), IL-3, stem cell factor (SCF), and insulin to promote erythroid
differentiation. Differentiation of Sptlc12/2 BMCs along the
erythroid lineage was not compromised in vitro, mimicking the
in vivo situation (Figure 5H; supplemental Figure 5F). Erythroid colony
formation was also not compromised in Sptlc12/2 (Figure 5I).
Loss of SPTLC1 decreased sphingomyelin levels (Figure 1B), which
is normally present at the plasma membrane. This decreased
sphingomyelin could affect cytokine signaling in myeloid cells. To
test this, Sptlc11/1 and Sptlc12/2 Lin2 cells were isolated, cultured
in murine SCF (mSCF) and IL-3 for 3 days, serum starved for 3 hours,
then stimulated with 50 ng/mL GM-CSF, macrophage colony-
stimulating factor (M-CSF), and granulocyte colony-stimulating factor
(G-CSF) for 10 minutes. GM-CSF receptor signaling, including
phosphorylated AKT (p-AKT), phosphorylated extracellular signal-
regulated kinase (p-ERK1/2), and phosphorylated STAT3 (p-STAT3)
were not decreased but ERK1/2 and STAT3 rather showed slightly
higher phosphorylation levels in the mutant (Figure 5J-J9). Similarly,
signaling via M-CSF and G-CSF was not compromised (supplemen-
tal Figure 5G-H). These experiments suggest that lowered sphingo-
myelin does not impair the signal transduction process.
ER stress disrupts granulopoiesis
Many lipid biosynthetic pathways operate within the membrane
environs of the ER, and dysregulation of these pathways has been
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Figure 4. Single-cell transcription and GSEA profiles of LK and MPP cells from Sptlc11/1 and Sptlc12/2. (A) A total of 3140 Sptlc11/1 and 2808 Sptlc12/2 cells
identified as LK by flow cytometry were divided into clusters based on individual gene-expression profiles. The plot shows a 2-dimensional representation (t-SNE) of tran-
scriptome profiles of the Sptlc11/1 and Sptlc12/2, with each cluster highlighted in a different color. The integrated Sptlc11/1 and Sptlc12/2 cells were represented in t-SNE
plots. (B) The percentage of cells expressing relative lineage-specific markers in individual clusters from Sptlc11/1 and Sptlc12/2 LK populations. (C) Heat maps of Sptlc11/1
and Sptlc12/2 LK populations expressing myeloid-specific gene markers (Mpo, Elane, Ctsg, Prtn3, Irf8, and Cebpe) and erythroid-specific gene markers (Apoe, Klf1, Rhd,
Hba.a1, Gata1, Gata2, Car1, and Car2). (D) Violin plots of the distributions of expression of Mpo, marker of the myeloid population, in LK cells. Comparison of expression
levels for LK cells in clusters C1, C3, C4, C5, C7, and C9 of Sptlc11/1 and Sptlc12/2 is shown. (E) Violin plots of the distributions of expression of Car2, a marker of the
erythroid population. Comparison of expression levels for LK cells in clusters C2 and C5 of Sptlc11/1 and Sptlc12/2 is shown. (F) The percentage of myeloid, erythroid, and
multilineage cells in the Sptlc11/1 and Sptlc12/2 LK populations. (G) A total of 3099 Sptlc11/1 and 1997 Sptlc12/2 cells identified as MPPs by flow cytometry were divided
into clusters based on individual gene-expression profiles. The plot shows a 2-dimensional representation (t-SNE) of transcriptome profiles of the Sptlc11/1 and Sptlc12/2,
3642 PARTHIBANE et al 26 NOVEMBER 2019 x VOLUME 3, NUMBER 22
D
ow
nloaded from
 https://ashpublications.org/bloodadvances/article-pdf/3/22/3635/1542516/advancesadv2019000729.pdf by U
N
IV O
F M
ASSAC
H
U
SETTS user on 04 D
ecem
ber 2019
proposed to induce ER stress and activate the unfolded protein
response (UPR).39-41 Therefore, we evaluated whether differentiat-
ing mutant cells exhibited ER stress and activation of the UPR.
Nucleated BMCs were isolated from Sptlc11/1 and Sptlc12/2mice
3 days after poly(I:C) injection and analyzed for expression of UPR
proteins by western blotting. The levels of Grp78 (binding
immunoglobulin protein [BiP]) and cleaved protein kinase R-line
endoplasmic reticulum kinase (PERK) products were increased in
the Sptlc12/2 BMCs (Figure 6A-A9). CMP/GMPs isolated from
these mice also showed elevated Xbp1s splice product compared
with the Sptlc11/1 controls (supplemental Figure 6A). In addition,
we found that BMC cultures of Sptlc12/2 that were induced to
differentiate along myeloid lineage displayed higher expression of
Grp78, p-IRE1a (p-inositol–requiring transmembrane kinase/endo-
nuclease 1a), PERK, and protein disulfide isomerase (PDI) than
control cultures, although calreticulin, a ER-resident protein,
remained unchanged, mirroring the difference noted earlier in the
nucleated BM samples (Figure 6B-B9).42 We also observed an
increase in Grp78 in the Gr11 and LK cells but not in LSK cells by flow
cytometry in chimeric mice 4 days after Sptlc1 deletion (Figure 6C-E;
supplemental Figure 6B-D). Evidence of ER stress was also observed
when we examined the mutant progenitor population that was
derived from the Lin2 cells (supplemental Figure 6E).
To validate whether ER stress was detrimental for granulopoiesis,
we used thapsigargin (Tg), a drug that induces ER stress by
inhibiting ER Ca21 ATPase (sarcoplasmic reticulum calcium trans-
port ATPase) activity.43 BMCs differentiated along myeloid lineage in
the presence of Tg exhibited a 42.4% decrease in Mac-11Gr-11
cells than the control (Figure 6F; supplemental Figure 6F). Grp78 and
PDI were elevated and Giemsa-stained cytocentrifuged slides reveal
a scarcity of myeloid cells (Figure 6G; supplemental Figure 6G).
GSEA analysis of LK
0.5 NES: 1.4
p-value = 0.01054
FDR q = 0.0533
MYELOID GENES
En
ric
hm
en
t s
co
re
(E
S)
LK - wild type (positively correlated)
0.4
0.3
0.2
0.1
0.0
-0.1
-0.2
-0.3
En
ric
hm
en
t s
co
re
(E
S)
ERYTHROID GENES
LK - knock out (positively correlated)
NES: -1.63
p-value = 0.0027
FDR q = 0.00210
0.1
0.0
-0.1
-0.2
-0.3
-0.4
-0.5
-0.6
-0.7
ELANE
PRTN3
MPO
CSF1R
CTSG
IRF8
FCGR3
CEBPE
MPEG1
TREM3
CEBPA
GFI1
CLEC5A
KLF2
CCL9
CSF3R
LYZ2
RGCC
SPI1
LGALS3
ANXA1
ANXA2
FCER1G
CSF2RA
FAM20C
FES
ITGAM
CD34
L3MBTL3
LCN2
Myeloid Genes
W
T-
1
W
T-
2
W
T-
3
K
O
-1
K
O
-2
K
O
-3
NAB2
TSC22D1
SMAD1
TFCP2L1
IRF6
PAX9
PIAS3
TEAD2
BACH1
JUN
PBX3
NFE2
ARNT2
HIC1
AR
PF4
PTRF
SPIB
MLLT3
EGR1
EPOR
PAX5
MEIS1
APOE
GATA2
GFI1B
ZFPM1
CAR2
GATA1
CAR1
Erythroid Genes
W
T-
1
W
T-
2
W
T-
3
K
O
-1
K
O
-2
K
O
-3
Low
R
elative expressionH
igh
I
GSEA analysis of MPP
En
ric
hm
en
t s
co
re
(E
S)
MPP - wild type (positively correlated)
ERYTHROID GENES
NES: 1.52
p-value = 0.0117
FDR q = 0.03007
0.5
0.6
0.7
0.4
0.3
0.2
0.1
0.0
-0.1
-0.2
En
ric
hm
en
t s
co
re
(E
S)
MYELOID GENES
MPP - wild type (positively correlated)
NES: 1.58
p-value = 0.0003
FDR q = 0.01922
0.5
0.6
0.4
0.3
0.2
0.1
0.0
-0.1
-0.2
Myeloid Genes
MPO
CSF1R
IRF8
ELANE
CTSG
PRTN3
IL31RA
GATA2
LCN2
CCL9
LYZ2
KLF2
ZBTB16
CEBPA
ZFPM1
JUN
SOX6
GAB2
RUNX1
MMP9
LGALS3
TGFBR3
ANXA2
ITGAM
CSF3R
KIT
TET2
GATA1
VEGFA
TAL1
W
T-
1
W
T-
2
W
T-
3
K
O
-1
K
O
-2
K
O
-3
W
T-
1
W
T-
2
W
T-
3
K
O
-1
K
O
-2
K
O
-3
EGR1
APOE
GATA2
KLF6
PF4
ZFPM1
SELP
JUN
KLF9
FOS
PTRF
GATA1
HDAC5
NFE2
SPIB
POU6F1
ALAS1
GFI1B
BACH1
NRIH3
EPOR
MEIS1
NDN
CAR2
ZFP37
TCS22D1
HAND1
NAB2
PIAS3
ZEP14
Erythroid Genes
Low R
elative expression
H
igh
J
Figure 4. (continued) with each cluster highlighted in a different
color The integrated Sptlc11/1 and Sptlc12/2 data set was repre-
sented in a t-SNE plot. (H) Violin plots of the distributions of
expression of Hspa5 and Pdia6, indicators of ER stress, in Sptlc11/1
and Sptlc12/2 MPP cells. (I-J) GSEA analysis of RNA-seq data
showing indicated gene sets with differentially regulated genes
between Sptlc11/1 and Sptlc12/2 in LK (I) and MPP (J) cell
populations, respectively. Heat map of top 30 genes were displayed.
Relative expression levels are indicated. FDR, false discovery rate;
NES, normalized enrichment score.
26 NOVEMBER 2019 x VOLUME 3, NUMBER 22 Sptlc1 IN MYEOLPOIESIS 3643
D
ow
nloaded from
 https://ashpublications.org/bloodadvances/article-pdf/3/22/3635/1542516/advancesadv2019000729.pdf by U
N
IV O
F M
ASSAC
H
U
SETTS user on 04 D
ecem
ber 2019
E
+/+ +/+ -/- -/-
Caspase 3
Actin
F
0.0025
**
%
 L
K 
ce
lls
An
ne
xin
V+
 &
 P
I+
 st
ain
80
60
40
20
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
G
ns
%
 L
SK
 c
ell
s
An
ne
xin
V+
 &
 P
I+
 st
ain
80
60
40
20
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
H
%
 C
D7
1-
Te
r11
9+
 c
ell
s
ns
2.0
1.5
1.0
0.5
0.0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
C
Mac1
G
r1
Sptlc1+/+ Sptlc1-/-
A
<0.0001
****
Nu
m
be
r o
f C
FU
-G
M 
(L
SK
) 1500
1000
500
0
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
B
Nu
m
be
r o
f C
FU
-G
M 
(L
K) 250
200
150
100
50
0
<0.0001
****
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
D
60
40
20
0
%
 M
ac
1+
Gr
1+
 c
ell
s
<0.0001
****
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
J
+/+ +/+-/- -/-
SPTLC1
Starved
Stimulated
(GM-CSF)
p-AKT
T-AKT
p-ERK
T-ERK
p-STAT3
T-STAT3
Sptlc1+/+ Sptlc1-/-
I
0.0407
Nu
m
be
r o
f C
FU
-E
 (L
SK
)
600
400
200
0
*
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
J'
ns
Ra
tio
 st
im
ula
te
d/
sta
rv
ed
 si
gn
al
2.5
2.0
1.5
1.0
0.5
0.0
**
*
pAKT
pERK
pSTAT3
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
Sp
tlc
1
+/
+
Sp
tlc
1
-/-
Figure 5. Myeloid differentiation defects in Sptlc12/2BMCs. In vitro culture. (A-B) The total numbers of CFUs for Sptlc11/1 and Sptlc12/2 FACS-sorted LK and LSK
cells. The results are from 4 Sptlc11/1 and 4 Sptlc12/2 mice. (C) Sptlc11/1 and Sptlc12/2 Lin2 cells were induced to differentiate in liquid culture with medium containing
GM-CSF and IL-3. After 4 days, cells were stained for Mac-1 and Gr-1. The results are from 3 Sptlc11/1 and 3 Sptlc12/2 mice. (D) The percentage of Mac-11Gr-11 cells was
plotted for Sptlc11/1 and Sptlc12/2. (E) Western blot analysis of cell extracts from BMCs cultured in the presence of GM-CSF and IL-3 for 4 days. Sptlc11/1 and Sptlc12/2
lysates were probed for caspase 3. (F) The percentages of LK cells staining positive for annexin V and PI were plotted for 4 Sptlc11/1 and 4 Sptlc12/2 21 days after poly(I:C)
injection. (G) The percentages of LSK cells staining positive for annexin V and PI were plotted for 4 Sptlc11/1 and 4 Sptlc12/2 21 days after poly(I:C) injection. (H) The
percentage of CD712Ter1191 cells was plotted for Sptlc11/1 and Sptlc12/2 cells. (I) The total numbers of CFU-E for Sptlc11/1 and Sptlc12/2 FACS-sorted LSK cells. The
results are from technical triplicates of samples from 3 Sptlc11/1 and 3 Sptlc12/2 mice. Representative photographs of LSKs differentiating into erythroid colonies taken after
10 days of solid culture (bright field microscopy; original magnification 32). (J) Lin2 cells isolated from Sptlc11/1 and Sptlc12/2 mice cultured in the presence of mSCF and
IL-3 for 3 days, serum starved for 3 hours followed by stimulated with GM-CSF (50 ng/mL) for 10 minutes at 37°C. Western blots for p-AKT, p-ERK1/2, and p-STAT3 and
their respective dephosphorylated forms. Data representative of 3 independent experiments. (J9) Quantitative data representative of 3 independent experiments. All graphs are
represented as mean 6 SEM. P , .05 is significant, calculated from the unpaired Student t test.
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Figure 6. Sptlc12/2BMCs exhibit ER stress that compromises myeloid differentiation. (A) Western blot analysis of Sptlc11/1 and Sptlc12/2 BM cells harvested
3 days after poly(I:C) injection. Lysates were probed for Grp78 and PERK. Cleaved PERK products were detectable in the Sptlc12/2. (A9) Quantitative data representative of 3
independent experiments. (B) Western blot analysis of cell extracts of Sptlc11/1 and Sptlc12/2 BMCs cultured for 4 days in the presence of GM-CSF and IL-3. Lysates were
probed for Grp78, p-IRE1a, PERK, PDI, and calreticulin. (B9) Quantitative data representative of 3 independent experiments. (C-E) The Grp78 (BiP) staining of Gr1, LK, and
LSK cells was plotted for 5 Sptlc11/1 and 5 Sptlc12/2 BMT mice, analyzed 4 days after poly(I:C) injection (n 5 5). (F) The wild-type BM cells were cultured in the presence
of GM-CSF and IL-3 factors in liquid culture with dimethyl sulfoxide (DMSO) (control) and Tg (10 nM) for 2 days and stained for Mac-1 and Gr-1. The percentage of
Mac-11Gr-11 cells was plotted for control and Tg-treated cells (n 5 6). (G) Western blot analysis of Grp78 and PDI for lysates from control and Tg-treated cells. Lanes: 1,
nucleated BMCs (before culture); 2, control; and 3, Tg-treated cells. (H) The percentages of radiolabeled fatty acids were plotted for the Sptlc11/1 and Sptlc12/2. (I)
Wild-type BM cells were cultured in the presence of GM-CSF and IL-3 with bovine serum albumin (BSA) (control) and with sodium palmitate (200 mM) for 4 days. The cells
were stained for Mac-1 and Gr-1. The percentage of Mac-11Gr-11 cells was plotted for control and palmitate-treated cells (n 5 6). (J) Western blots of Grp78 and PDI for
lysates of control and palmitate-treated cells. Lanes: 1, nucleated BMCs; 2, control; and 3, palmitate-treated cells. (K) The percentage of CD712Ter1191 cells was plotted for
control and Tg-treated cells (n 5 7). (L) The percentage of CD712Ter1191 cells was plotted for control and palmitate-treated cells (n 5 7). All graphs are represented as
mean 6 SEM. P , .05 is significant, calculated from the unpaired Student t test.
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To study whether the absence of SPTLC1 affects the levels of its
substrate, fatty acid, we metabolically labeledSptlc11/1 andSptlc12/2
BMCs with [14C] acetate for 36 hours in medium containing IL-3 and
GM-CSF and resolved the lipids on thin layer chromatography
(supplemental Figure 6H). Fatty acid levels in the Sptlc12/2 were
found to be .2.5-fold higher than in the control (Figure 6H).
To test whether palmitate could induce ER stress and diminish
myeloid differentiation as observed in the Sptlc12/2, we treated
wild-type BMCs with 200 mM sodium palmitate for 4 days.44 These
cultures showed a substantial decrease in Mac-11Gr-11 cells
(Figure 6I; supplemental Figure 6I-J) and Grp78 and PDI expression
levels were increased (Figure 6J). We observed no significant
changes in the numbers of immature erythroid cells in the Tg-
treated cultures compared with control cultures (Figure 6K;
supplemental Figure 6K). Similarly, in palmitate-treated cultures,
no difference was observed in the immature erythroid population
(Figure 6L; supplemental Figure 6L), indicating that erythropoiesis
was not compromised by Tg- or palmitate-induced ER stress.
Myeloid differentiation was also compromised in BM cultures
subjected to treatment with other ER stress inducers such as
tunicamycin and 2-deoxyglucose, thus confirming that ER stress
affects myeloid differentiation (supplemental Figure 6M-N). Collectively,
these results support the notion that acute accumulation of palmitic
acid could contribute to the ER stress in part, in turn interfering with the
process of myelopoiesis while sparing erythropoiesis.
Discussion
Sphingolipids are integral membrane components and changes in
their metabolic flux are anticipated to impact organelle physiology.
Deficiency of ceramide phosphoethanolamine in Drosophila leads
to defects at the plasma membrane, resulting in accelerated aging
and photosensitive epilepsy; increased ceramide affects organismal
homeostasis requiring adaptations involving glycolytic and lipolytic
pathways.45-47 De novo biosynthesis of sphingolipids is initiated in
the ER, a dynamic tubular structure that is not only involved in the
synthesis of lipids, but is also the primary site for the biosynthesis,
maturation, and folding of proteins for the secretory pathway.
Missense mutations in Sptlc1 and Sptlc2 cause autosomal-
dominant hereditary sensory neuropathy.48 Cultures of lymphoblast
from the Sptlc1 mutant patients had defects in mitochondria. They
also exhibited decreased BiP and Ero1-La expression, indicating
ER dysfunction.49 Recently, it was shown that wild-type CD81
T cells require SPTLC2 function to promote metabolic fitness and
hereditary sensory autonomic neuropathy-1 patients and mice null
for the Sptlc2 gene were found to be defective in CD81 T function
due to ER stress.50 High-density lipoprotein–bound sphingosine 1-
phosphate has been shown to suppress lymphopoiesis.51
The functional studies reported here reveal a vital and distinct
function for Sptlc1 in hematopoiesis. Initial identification of its role in
hematopoiesis came from the CKO allele using Mx1-Cre–induced
ablation in the HSCs. Sptlc1-deleted mice show severe hemato-
poietic defects and die soon after the deletion of the gene.
Transplantation studies recapitulate the hematopoietic phenotype
confirming its intrinsic role. Specifically, loss of Sptlc1 in adult
chimeric mice leads to an initial expansion of MPPs, a decrease
in CMPs/GMPs, and a decrease in neutrophil differentiation.
Sptlc12/2 mice do not survive beyond 1 month due to block-
ade in myeloid differentiation. Competitive transplantation experi-
ments provided us with an avenue to distinguish between the
cell-autonomous effects of Sptlc1 from the superimposed effects
due to compensatory mechanisms. In the absence of peripheral
cytopenia, the contribution of the Sptlc12/2 cells to HSCs,
progenitors, and the lineage-positive cells is rapidly reduced. The
loss of mature blood cells elicits compensatory stress-induced
hematopoiesis in the noncompetitive setting.52 The limited myelo-
proliferative phenotype in the CKO is explained by ER stress
following Sptlc1 deletion in the progenitor population attributed, at
least in part, to accumulation of palmitic acid. The mutant shows
a significant increase in the fatty acids, and it is known that palmitic
and stearic acids induce ER stress in hepatocytes.44 We found that
addition of palmitate to myeloid cultures induces ER stress and
causes a decrease in granulocyte formation similar to the
phenotype observed in the Sptlc12/2. This contribution can be
further substantiated by combining Sptlc1 and Atgl double
knockout using Mx-1Cre–deleted conditional alleles. The loss of
adipose triglyceride lipase should help address whether hydrolysis
of triacylglycerol influences the steady-state level of fatty acid.
Reducing its contribution in the double mutant could mitigate the
component of ER stress arising from decreased utilization by the de
novo sphingolipid biosynthetic pathway in Sptlc1 null mice.53,54 The
lack of sphingolipid metabolic flux in the ER could also induce stress
in the Sptlc1 mutant mice. The ER is a sensor that collates signals
from varied sources and responds appropriately during growth and
division of a cell.55 It is widely connected within the cell to other
organelles and is therefore a functionally and architecturally
complex intracellular hub.56 Given that progenitor cells are
committing to lineages endowed with unique functions, it is likely
that the ER undergoes profound changes during these stages of
commitment and is thus sensitive to perturbations of ER function.
Indeed, when the RNA isolated for RNA-seq was probed for
701 ER-associated genes from the MSigDB (software.broadinsti-
tute.org/gsea/msigdb/collections.jsp#H), we find an enrichment for
these genes in the control LK population compared with the MPP
cells (supplemental Figure 7A). Such enrichment was not found
when HSCs were compared with MPP (not shown) or even in the
Sptlc1mutant LK cells (supplemental Figure 7B), indicating that perhaps
such enrichment was mostly confined to the myeloid progenitor cells that
were severely reduced in the mutant BMCs. Because the Sptlc1 mutant
LK cells do not show enrichment of ER genes, a comparison of LK cells
of Sptlc11/1 and Sptlc12/2 shows an enrichment in the wild-type
compared with the mutant (not shown).
Several of the enzymes of the sphingolipid biosynthetic pathway and
their associatedmetabolites have been reported to be correlatedwith
acute and chronic myeloid leukemia.57 No correlation of SPTLC1
status to myeloid malignancies has been reported. Given that
SPTLC1 deficiency results in poor myeloid differentiation and
expansion of the LSK compartment, it would be interesting to
examine whether the loss of SPTLC function has any correlation to
either pathogenesis or outcome of myeloid malignancies.
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